Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-03-000876
Filing Date
2003-11-19
Accepted
2003-11-19 13:05:35
Documents
3
Period of Report
2003-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o11239e6vk.htm 6-K 207260
3 GRAPHIC o11239o1123901.gif GRAPHIC 2352
4 GRAPHIC o11239o1123902.gif GRAPHIC 1778
  Complete submission text file 0001130319-03-000876.txt   213120
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 031012306
SIC: 2834 Pharmaceutical Preparations